These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 3675734)

  • 1. Technetium-99m radiopharmaceutical preparation by surface adsorbed stannous ions.
    Salehi N; Lichtenstein M; Pojer PM
    J Nucl Med; 1987 Jun; 28(6):1041-6. PubMed ID: 3675734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technical problems associated with the production of technetium Tc 99m tin(II) pyrophosphate kits.
    Kowalsky RJ; Dalton DR
    Am J Hosp Pharm; 1981 Nov; 38(11):1722-6. PubMed ID: 7304626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukocyte labeling with technetium-99m tin colloids.
    Mock BH; English D
    J Nucl Med; 1987 Sep; 28(9):1471-7. PubMed ID: 3625299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Sn(II) ion concentration and heparin on technetium-99m red blood cell labeling.
    Rao SA; Knobel J; Collier BD; Isitman AT
    J Nucl Med; 1986 Jul; 27(7):1202-6. PubMed ID: 3014088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and biological distribution of technetium diphosphonate radiotracers synthesized without stannous ion.
    Deutsch E; Libson K; Becker CB; Francis MD; Tofe AJ; Ferguson DL; McCreary LD
    J Nucl Med; 1980 Sep; 21(9):859-66. PubMed ID: 6774066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stoichiometric Tc-99m RBC labeling using stable kit solutions of stannous chloride and EDTA: concise communication.
    Mock BH; Wellman HN
    J Nucl Med; 1984 Aug; 25(8):881-6. PubMed ID: 6431061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 99mTc-labelled compounds prepared with sodium dithionite as reducing agent.
    Vilcek S; Kalincák M; Machán V
    Nuklearmedizin; 1981 Dec; 20(6):283-9. PubMed ID: 6460222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of formamidine sulfinic acid and other reducing agents for use in the preparation of Tc-99m labeled radiopharmaceuticals.
    Fritzberg AR; Lyster DM; Dolphin DH
    J Nucl Med; 1977 Jun; 18(6):553-7. PubMed ID: 192859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Charge and nature of technetium species produced in the reduction of pertechnetate by stannous ion.
    Owunwanne A; Marinsky J; Blau M
    J Nucl Med; 1977 Nov; 18(11):1099-105. PubMed ID: 915087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative evaluation of techniques for rapid and efficient in vivo labeling of red cells with [99mTc] pertechnetate.
    Hamilton RG; Alderson PO
    J Nucl Med; 1977 Oct; 18(10):1010-3. PubMed ID: 903468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technetium-99m labeling by means of stannous pyrophosphate: application to bleomycin and red blood cells.
    Bardy A; Douyé H; Gobin R; Beydon J; de Tovar G; Pannecière C; Hégésippe M
    J Nucl Med; 1975 May; 16(5):435-7. PubMed ID: 53279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte labeling with technetium-99m tin colloids.
    Hanna R; Lomas F; Sullivan P
    J Nucl Med; 1988 May; 29(5):729-30. PubMed ID: 3373309
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro technetium-99m red blood cell labeling using commercial stannous pyrophosphate.
    Zimmer AM
    Am J Hosp Pharm; 1977 Mar; 34(3):264-7. PubMed ID: 857670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium-99m labeling of red blood cells: in vitro evaluation of a new approach.
    Kelbaek H
    J Nucl Med; 1986 Nov; 27(11):1770-3. PubMed ID: 3772511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current topics in radiopharmaceuticals in Japan (V). Quality of "kit"-made radiopharmaceuticals (2)--Radiochemical purity of 99mTc radiopharmaceuticals].
    Yokoyama A
    Radioisotopes; 1984 Apr; 33(4):237-46. PubMed ID: 6089272
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of tin-technetium colloid in technetium-labeled albumin preparations.
    Petit WA; DeLand FH; Pepper GH; Blanton L
    J Nucl Med; 1978 Apr; 19(4):387-92. PubMed ID: 632927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved protein labeling by stannous tartrate reduction of pertechnetate.
    Pettit WA; DeLand FH; Bennett SJ; Goldenberg DM
    J Nucl Med; 1980 Jan; 21(1):59-62. PubMed ID: 7356741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Labeling efficiency and biodistribution of Technetium-99m labeled nanoparticles: interference by colloidal tin oxide particles.
    Banerjee T; Singh AK; Sharma RK; Maitra AN
    Int J Pharm; 2005 Jan; 289(1-2):189-95. PubMed ID: 15652211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo labeling of red blood cells with Tc-99m with stannous pyridoxylideneaminates.
    Kato M
    J Nucl Med; 1979 Oct; 20(10):1071-4. PubMed ID: 536758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative biodistribution studies of technetium-99 m radiolabeled amphiphilic nanoparticles using three different reducing agents during the labeling procedure.
    Geskovski N; Kuzmanovska S; Simonoska Crcarevska M; Calis S; Dimchevska S; Petrusevska M; Zdravkovski P; Goracinova K
    J Labelled Comp Radiopharm; 2013 Dec; 56(14):689-95. PubMed ID: 24339006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.